Figure 2From: Promising treatment outcomes of intensity-modulated radiation therapy for nasopharyngeal carcinoma patients with N0 disease according to the seventh edition of the AJCC staging system Five year overall survival, local relapse-free survival and distant metastasis-free survival for patients with N0 disease according to the seventh edition of the American Joint Committee on Cancer (AJCC) nasopharyngeal carcinoma staging system.Back to article page